Khavinson Bioregulators: The Complete Research Guide to Epitalon, Pinealon, Prostamax & Short-Chain Peptides

There’s a category of peptide research that’s been running for over forty years, produced hundreds of peer-reviewed papers, and has largely flown under the radar of Western geroscience — until recently. Khavinson bioregulators sit at the intersection of aging biology, epigenetics, and tissue-specific gene regulation. Short-chain peptides, usually two to four amino acids, with proposed mechanisms involving chromatin remodeling and transcriptional control. The science is old enough to have a real literature behind it. It’s also unusual enough that investigators approaching it for the first time benefit from some orientation.

This guide covers the framework, the key compounds — Epitalon, Pinealon, Prostamax — and several others that appear consistently in the geroscience literature. It also covers where the evidence is genuinely strong, where it’s weaker, and what the honest research questions look like in 2025–2026. For laboratory and preclinical research use only.

---

Who Is Vladimir Khavinson?

Vladimir Khavinson is the Director of the St. Petersburg Institute of Bioregulation and Gerontology, a position he’s held since the institute was founded in 1992 under the Russian Academy of Medical Sciences. His research career started in Soviet military medicine in the 1970s — specifically in work on restoring tissue function under extreme physiological stress. That early focus on restoration and resilience shaped everything that followed.

He’s not a fringe figure. Over 700 peer-reviewed publications. Full member of the Russian Academy of Sciences. The bioregulator research program he developed has been running continuously for more than four decades, producing a body of literature that spans cell culture, animal models, and longitudinal population studies. Western scientists have been skeptical of some of it — partly due to publication in Russian-language journals, partly due to the broad claims made — but the raw volume of experimental output has made engagement unavoidable for anyone working seriously in aging biology.

The central theory: short peptides derived from specific organ tissues carry sequence-specific information that interacts directly with DNA and chromatin structure — effectively signaling aging cells to restore earlier gene expression patterns. Whether that framing is ultimately correct at the mechanistic level is still an open question. What isn’t open is that the experimental results have been reproducible enough, in enough models, to warrant serious investigation.

---

Cytomaxes and Cytogens: The Two-Track Framework

Khavinson’s group developed two generations of compounds that appear interchangeably under the “bioregulator” umbrella:

Cytomaxes are the first generation — complex peptide fractions extracted from specific organs. Thymus extract, pineal gland extract, prostate extract, brain cortex extract. They’re not pure single peptides; they’re active fractions with multiple components, developed before the individual active sequences were characterized. Many of the older clinical research studies in Khavinson’s literature use cytomaxes rather than synthetic versions.

Cytogens (sometimes written cytogenes) are the second generation — synthetic short-chain peptides with defined sequences, developed once researchers isolated the active components from the cytomaxe fractions. These are the compounds that get discussed in modern research contexts: tetrapeptides, tripeptides, dipeptides with known amino acid sequences and reproducible synthesis. Epitalon is a cytogen. So are Pinealon, Vilon, and most others in the list below.

The distinction matters for reading the literature. Early papers use cytomaxes; later papers use cytogens. The mechanistic proposals are similar but the experimental materials are not directly comparable.

---

The Short-Chain Peptide Mechanism — Chromatin and Gene Expression

Most bioactive peptides work at cell surface receptors. That’s the familiar story: ligand binds receptor, second messenger cascade fires, gene expression changes indirectly. Khavinson’s bioregulators propose something more direct. Short enough to penetrate cell nuclei, these peptides are hypothesized to interact with chromatin — binding specific DNA sequences in promoter regions through steric and electrostatic complementarity, altering histone modification patterns, and changing the accessibility of regulatory regions to transcription factors.

The sequence specificity is the key claim. Not random binding — sequence-specific recognition, analogous to how certain transcription factors bind defined promoter motifs. Specific dipeptide and tripeptide motifs matching corresponding nucleotide sequences. The result, in Khavinson’s framework, is tissue-specific gene expression modulation — “reminding” aging cells of their original transcriptional state.

Is this fully proven? Not at the level molecular biologists typically demand. The epigenetic interaction model is supported by binding studies and cocrystallization data from Khavinson’s group, but independent replication using contemporary structural biology tools is limited. What’s supported more broadly is the downstream functional observation: these short peptides alter gene expression in ways consistent with the proposed mechanism, and the effects are sequence-specific. The full mechanistic picture remains an active research question.

---

Epitalon: The Telomere Researcher’s Focus

What It Is

Epitalon (also spelled Epithalon) is a synthetic tetrapeptide: Ala-Glu-Asp-Gly. Four amino acids. Molecular weight of approximately 390 daltons. It was derived from Epithalamin — the original pineal gland cytomaxe — and is now the most extensively studied of all Khavinson bioregulators. The reason for that attention is telomere biology.

The Telomere Research

The headline finding from Epitalon research is telomerase activation. Multiple studies — primarily from Khavinson’s group, with some independent replication — have documented that Epitalon exposure increases telomerase activity in cell culture models, with associated elongation of telomere length in aged cells. Given that telomere shortening is one of the most well-characterized hallmarks of cellular aging (per the Lopez-Otin framework), a compound that reliably activates telomerase is immediately interesting to geroscience researchers.

The proposed mechanism involves Epitalon modulating expression of the TERT (telomerase reverse transcriptase) gene through the chromatin interaction pathway described above. In vitro work has shown increased TERT mRNA and protein in Epitalon-exposed cells alongside the telomerase activity findings. The correlation is consistent. Whether the chromatin interaction model is the correct mechanistic explanation for it — or whether other pathways are involved — is still being worked out.

Beyond telomere biology, Epitalon research includes data on melatonin synthesis restoration in aged animals (via pineal gland activity upregulation), antioxidant effects, and tumor incidence reduction in long-term rodent studies. The pineal connection is interesting: melatonin’s role in circadian regulation, antioxidant defense, and aging is well-established, and a compound that influences pineal output has multiple research angles worth pursuing independently of the telomere story.

Longevity Research in Animal Models

Khavinson’s group has published several long-term rodent studies showing extended median and maximum lifespan in Epitalon-exposed animals compared to controls. The effect sizes in these studies are notable — not marginal. But they come primarily from one research institute, and independent replications with modern aging biology endpoints have been limited. That’s a real gap in the evidence base, and one that makes confident mechanistic interpretation difficult for investigators outside the group. The findings are compelling enough to warrant investigation; they’re not established enough to be treated as settled.

Research Applications

• Telomerase activation and telomere elongation research in aged cell models
• Pineal gland biology and melatonin synthesis studies
• Aging hallmarks research — cellular senescence, oxidative stress
• Long-term rodent model work on age-associated pathology incidence

---

Pinealon: Neuroprotection and Circadian Research

What It Is

Pinealon is a synthetic tripeptide: Glu-Asp-Arg. Three amino acids, derived from the same pineal gland source material as Epitalon, but with a focus that’s clearly oriented toward the nervous system rather than telomere biology. The research literature on Pinealon is smaller than Epitalon’s but has grown meaningfully in the past decade.

Neuroprotective Findings

The core Pinealon research involves neuroprotection in ischemic and oxidative stress models. Cell culture studies using neural cell lines under hypoxic conditions have found reduced apoptotic markers and improved cell viability with Pinealon exposure. Rodent ischemia models have shown reduced infarct volume and improved behavioral outcomes. Anti-inflammatory effects in neural tissue — reduced IL-1β, TNF-α — have been reported alongside the neuroprotective findings, suggesting multiple potential mechanisms rather than a single pathway.

The circadian angle is active too. Pineal-derived compounds have a natural research connection to circadian rhythm regulation, and there’s work examining Pinealon’s effects on sleep architecture markers and circadian gene expression in aged animal models. The findings are preliminary but interesting, particularly for researchers working on the circadian biology of aging.

Research Applications

• Neural ischemia and oxidative stress protection models
• Circadian rhythm regulation in aging contexts
• Neuroinflammation — cytokine profiles in neural environments
• Age-associated cognitive decline — behavioral outcome research in rodent models

---

Prostamax: The Prostate-Specific Bioregulator

What It Is

Prostamax (sometimes called Prostamaxin) is the bioregulator derived from prostate tissue extract — a zinc-binding short-chain peptide with research interest concentrated in prostate biology and urogenital tissue function. It represents the tissue-specificity principle of the Khavinson framework applied to a single organ system.

Research Findings

The mechanism involving zinc binding is notable. Zinc is a critical cofactor in prostate tissue — involved in citrate metabolism, testosterone conversion, and multiple enzymatic functions. Prostamax’s zinc-binding properties may underlie some of its observed effects on prostate-specific gene expression in animal models.

The research literature documents effects on prostate tissue histology in aged rodents: normalized cellular architecture, reduced inflammatory markers, and favorable shifts in androgen receptor-related gene expression. These findings place Prostamax in the context of prostate aging biology research — an area with obvious translational relevance but where Prostamax specifically sits in early preclinical stages outside Khavinson’s own work.

Research Applications

• Prostate aging biology and age-associated tissue remodeling
• Zinc-dependent enzymatic function in urogenital tissue
• Androgen receptor signaling in aged prostate tissue models

---

Other Key Bioregulators in the Khavinson Framework

Vilon (Lys-Glu)

A dipeptide with thymus-derived origins. Vilon research focuses on immune function in aged animals — specifically restoration of T-lymphocyte activity and cytokine production patterns toward younger profiles. Among the most studied of the cytogen dipeptides.

Thymalin

The original thymus cytomaxe. Unlike the cytogens, Thymalin is a complex extract rather than a defined sequence. It has the longest clinical investigational history of any compound in the bioregulator literature — longitudinal studies from Khavinson’s group spanning decades — but the undefined composition complicates mechanistic interpretation.

Cortagen (Ala-Glu-Asp-Pro)

A tetrapeptide derived from brain cortex. Research focuses on neural plasticity, BDNF expression, and cognitive function in aged rodent models. Structural similarity to Epitalon — both are tetrapeptides — but distinct in sequence and tissue target.

Vesugen (Lys-Glu-Asp)

A tripeptide derived from vascular tissue. Research interest in endothelial function, vascular inflammation markers, and age-associated changes in vessel wall biology. The vascular aging angle has attracted attention given the cardiovascular disease burden in aging populations.

Cardiogen (Ala-Glu-Asp-Lys)

Cardiac tissue-derived tetrapeptide. Research in cardiomyocyte protection models, age-associated heart function changes, and cardiac gene expression. Published animal data includes findings on reduced cardiac fibrosis markers and improved ejection fraction metrics in aged rodent models.

---

Compound Overview Table

Compound	Sequence	Source Tissue	Primary Research Focus	Evidence Level
Epitalon	Ala-Glu-Asp-Gly	Pineal gland	Telomere/telomerase, melatonin, longevity	Strongest; largest published dataset
Pinealon	Glu-Asp-Arg	Pineal gland	Neuroprotection, circadian, neuroinflammation	Moderate; growing literature
Prostamax	Zinc-binding peptide	Prostate tissue	Prostate aging, androgen signaling, zinc biology	Limited; primarily Khavinson group
Vilon	Lys-Glu	Thymus	Immune function restoration, T-lymphocyte biology	Moderate; thymus connection well-characterized
Thymalin	Complex extract	Thymus	Immune aging, longest longitudinal record	Extensive historical data; complex composition
Cortagen	Ala-Glu-Asp-Pro	Brain cortex	Neural plasticity, BDNF, cognitive aging	Early; primarily animal models
Vesugen	Lys-Glu-Asp	Vascular tissue	Endothelial function, vascular aging	Early; emerging research
Cardiogen	Ala-Glu-Asp-Lys	Cardiac tissue	Cardiac aging, cardiomyocyte protection	Early; animal model data available

---

The Epigenetic Mechanism: What’s Established and What Isn’t

The most ambitious claim in the Khavinson bioregulator literature is that these short peptides interact directly with DNA and chromatin — binding specific nucleotide sequences in promoter regions and altering gene expression through histone modification changes. That’s a meaningful mechanistic claim that goes well beyond what most peptide research proposes.

What’s established: Khavinson’s group has published binding studies showing short-chain peptides interact with double-stranded DNA in a sequence-selective manner. Cocrystallization data has been published. Computational modeling of peptide-DNA interaction geometries has been performed. The evidence for some form of direct chromatin interaction is real and isn’t based solely on functional observations.

What’s not fully established: The precise stoichiometry and affinity of these interactions in living cells. Whether the chromatin binding model fully explains the downstream gene expression changes, or whether other mechanisms (including indirect ones, via GPCR or nuclear receptor pathways) are also contributing. And critically: independent structural characterization using modern cryo-EM, X-ray crystallography, or ChIP-seq approaches has been limited. The mechanistic evidence is suggestive rather than definitive by the standards contemporary structural biology applies.

For investigators approaching this literature, that ambiguity is worth holding. The functional findings — telomerase activation, neuroprotection, immune function restoration — are better supported than the specific epigenetic mechanism proposed to explain them.

---

Limitations of the Current Evidence Base

Direct about the gaps: most of the published Khavinson bioregulator literature comes from one research institution. That concentration raises questions about replication independence that would be resolved if other groups engaged more systematically. A handful of independent groups have published work in this area — particularly on Epitalon and Thymalin — but the volume of independent replication remains lower than the evidence base’s age would suggest it should be.

There’s also a comparison problem: the cytomaxe studies (complex extracts) and cytogen studies (defined synthetic peptides) are often cited together as if they’re directly comparable. They’re not. Complex extracts contain multiple active components; results from cytomaxe studies don’t cleanly predict the behavior of the derived synthetic peptides, even when the active fraction was the basis for the synthetic design.

Finally, many of the most compelling findings come from aging biology endpoints — lifespan extension, cancer incidence reduction, cognitive aging trajectories — that are inherently long-timeline measurements. The existing long-term rodent studies are valuable, but they’re not the most recent (most were published in the 1990s–2000s) and haven’t been repeated with modern aging biology endpoints like biological age clocks, senescent cell burden, or organ-level omics profiling.

---

Why 2025–2026 Interest Is Accelerating

Several converging factors are driving renewed attention. The longevity research field has expanded dramatically — funding, institutional support, and new investigators — and is systematically revisiting older findings with modern tools. Epitalon’s telomerase findings, in particular, sit squarely at the intersection of current interest in the hallmarks of aging. The Horvath biological age clock literature, the senescence biology field, the NAD+/sirtuin research community — all of these have created investigators with both the motivation and the tools to engage with bioregulator research properly.

The short-chain peptide field more broadly is also maturing. BPC-157, TB-500, and related compounds have generated significant modern research programs, creating infrastructure and investigator expertise that transfers reasonably well to Khavinson compounds. Researchers already working in the peptide biology space are encountering bioregulators and finding the entry point lower than it once was.

All compounds described in this article are for laboratory and preclinical research use only. Not for human administration or veterinary use outside approved research protocols. Investigators should follow all applicable institutional and regulatory requirements when working with these compounds.

---

Frequently Asked Questions

What is Epitalon and what is the core research finding?

Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from the pineal gland cytomaxe Epithalamin. The most studied finding is telomerase activation in aged cell models — increased TERT expression and associated telomere elongation — along with pineal gland activity restoration and antioxidant effects in animal studies. For research use only.

How do cytomaxes differ from cytogens?

Cytomaxes are complex organ tissue extracts (the first generation of Khavinson compounds), while cytogens are defined synthetic short-chain peptides (the second generation, developed after active fractions were isolated and characterized). Most modern research uses cytogens because their defined composition allows reproducible synthesis and cleaner mechanistic interpretation. For research use only.

What is the proposed chromatin interaction mechanism?

Khavinson’s group proposes that short-chain peptides penetrate cell nuclei and bind specific DNA sequences in promoter regions through sequence-specific steric and electrostatic complementarity. This modulates histone modification states and alters transcription factor recruitment. Binding evidence exists from Khavinson’s published work; full mechanistic characterization by independent structural biology approaches remains limited. For research use only.

What are the main gaps in the Khavinson bioregulator evidence base?

Primary gaps include: limited independent replication from outside Khavinson’s institute; conflation of cytomaxe and cytogen results in citation; long-term lifespan studies not repeated with modern biological aging endpoints; and mechanistic characterization of the chromatin interaction model requiring independent structural validation. For research use only.